pharynx cancer: A primary or metastatic malignant neoplasm that affects the pharynx.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
330 |
4. Check minimum number of eventsNone |
330 |
5. Include endpointsNone |
330 |
6. Filter based on genotype QC (FinnGen only) |
294 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum pharyngis non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pharynx, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Neoplasms
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1705 | 921 | 768 |
| Only index persons | 1541 | 851 | 690 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 52.22 | 51.72 | 52.86 |
| Only index persons | 51.94 | 51.56 | 52.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 294 | 176 | 118 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | 55.96 | 53.85 | 59.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 310
- Matched controls
- 3100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
+∞
307.7
286
*
ENA10
NOMESCO Finland
Biopsy of pharynx
325.5
55.1
54
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.8
25.5
51
101
21099
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Pharynx unspecified
+∞
17.9
17
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
14.5
16.8
28
21
JDB10
NOMESCO Finland
Percutaneous gastrostomy
24.7
16.7
23
10
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.4
16.0
44
113
EMA10
NOMESCO Finland
Biopsy of tonsil
38.1
14.6
18
5
R21
ICPC
Throat symptom/complaint
2.7
13.6
97
449
EHA10
NOMESCO Finland
Biopsy of palate
39.3
12.3
15
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
124.4
11.5
12
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
18.7
10.8
16
9
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
29.2
10.8
14
5
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
13.6
10.8
18
14
D10.09
ICD-10 Finland
Benign tumor of the lip UNS
103.1
9.5
10
*
R07.0
ICD-10 Finland
Pain in throat
3.4
9.0
34
109
UJC01
NOMESCO Finland
Scopy of lower throat
14.6
8.8
14
10
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.3
8.1
16
18
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
34.3
8.1
10
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
8.0
129
812
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
7.9
103
599
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
7.7
91
509
A02BC02
ATC
pantoprazole; systemic
2.0
7.3
220
1694
GBB00
NOMESCO Finland
Tracheostomy
12.4
7.1
12
10
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
12.4
7.1
12
10
WX402
NOMESCO Finland
General anaesthesia
2.1
6.9
83
466
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.3
6.9
12
11
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
6.8
28
94
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
17.2
6.8
10
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
6.5
136
919
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
71.3
6.4
7
*
A07AA02
ATC
nystatin; oral
3.1
6.4
27
92
UJF32
NOMESCO Finland
Coloscopy
2.0
6.4
89
524
UDC00
NOMESCO Finland
Ear microscopy
2.8
6.4
33
127
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
6.3
97
591
SPAT1153
SPAT
Removal of sutures
1.9
6.3
100
616
EMB10
NOMESCO Finland
Tonsillectomy
3.3
6.3
24
77
C10.3
ICD-10 Finland
Malignant neoplasm: Posterior wall of oropharynx
+∞
6.3
6
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.1
6.3
17
43
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
6.2
228
1826
J39.2
ICD-10 Finland
Other diseases of pharynx
10.3
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
109
554
2.49
12.41
1.7
1.6
—
—
—
0
0
191
1374
2.02
8.09
8.4
7.0
1.21
1.21
mmol/l
0.18
160
1184
25
73
3.64
7.57
1.3
1.3
—
—
—
0
0
170
1204
1.91
7.21
5.1
4.6
35.88
35.84
g/l
0.04
159
1140
169
1238
1.80
6.04
7.9
6.1
1.20
1.21
mmol/l
0.80
156
1138
194
1503
1.78
5.53
6.3
6.7
10.54
11.50
umol/l
0.71
189
1429
168
1257
1.73
5.34
14.6
12.0
1.21
1.22
inr
0.08
146
1037
167
1259
1.71
5.07
2.7
2.5
76.12
76.77
nmol/l
0.10
150
1130
84
531
1.80
4.72
1.8
1.7
489.46
25602203.64
pmol/l
0.50
65
457
198
1599
1.66
4.33
11.1
10.1
4.29
4.06
e9/l
0.73
167
1402
64
384
1.84
4.23
11.1
7.3
104.09
104.36
mmol/l
0.18
64
384
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
63
2.97
4.13
2.1
2.5
0.32
0.35
iu/ml
—
10
37
38
192
2.12
4.09
1.6
1.5
—
—
—
0
0
166
1296
1.60
4.06
3.2
2.7
—
—
estimate
—
0
0
104
726
1.65
4.00
2.1
2.1
2.93
2.91
mg/l
0.03
90
627
54
313
1.88
3.96
9.6
7.9
1.88
0.78
mmol/l
1.32
41
267
71
448
1.76
3.96
1.9
1.9
—
—
—
0
0
75
488
1.71
3.74
3.3
2.8
1.00
0.93
e6/l
0.11
47
247
110
793
1.60
3.67
3.9
3.1
0.33
0.47
e6/l
0.51
82
573
290
2665
2.37
3.59
22.3
15.6
26.64
23.41
mg/l
1.09
260
2195
38
203
1.99
3.54
4.5
3.3
79.01
79.15
ng/l
0.01
31
177
304
2892
3.64
3.51
33.6
24.1
39.97
40.45
%
1.12
299
2863
304
2892
3.64
3.51
32.7
23.6
4.43
4.50
e12/l
1.37
293
2835
304
2890
3.68
3.50
32.8
23.7
258.91
250.95
e9/l
1.11
295
2844
99
705
1.59
3.44
2.7
2.7
327.39
340.24
umol/l
0.65
82
621
110
803
1.57
3.44
1.7
1.6
20.55
21.06
nmol/l
0.12
93
663
239
2082
1.65
3.35
5.5
4.4
14.75
14.78
pmol/l
0.07
214
1893
120
900
1.54
3.30
2.9
2.5
55.13
67.16
u/l
0.98
112
836
68
446
1.67
3.26
2.3
2.2
2.26
2.33
g/l
0.33
62
409
69
455
1.66
3.25
3.4
2.9
1.60
2.46
e6/l
0.78
41
215
10
24
4.27
3.22
1.4
1.3
—
—
—
0
0
114
850
1.54
3.21
2.2
2.1
126.65
159.73
u/l
1.02
108
805
273
2479
1.85
3.12
6.8
5.4
2.03
1.87
mu/l
0.70
252
2281
240
2113
1.60
3.01
9.2
8.4
76.24
79.43
u/l
0.92
233
2001
54
341
1.71
2.97
2.0
1.8
—
—
—
0
0
21
95
2.30
2.97
2.3
3.1
—
—
—
0
0
122
943
1.48
2.82
4.1
3.4
2.34
2.36
mmol/l
0.83
112
858
19
86
2.29
2.70
1.1
1.1
—
—
—
0
0
69
477
1.57
2.66
2.3
2.3
11.91
13.21
umol/l
0.70
64
443
77
549
1.54
2.59
3.2
2.8
2.45
2.45
mmol/l
0.10
72
498
75
533
1.54
2.56
1.4
1.3
16.88
30.24
iu/ml
1.49
23
165
64
441
1.57
2.50
1.9
1.6
1184.53
1268.76
nmol/l
0.33
45
336
123
971
1.44
2.49
2.8
3.1
27.66
33.42
u/l
1.61
116
916
96
724
1.47
2.46
1.5
1.3
2.28
1.80
u/ml
0.16
23
208
104
797
1.46
2.45
3.4
3.3
2096.53
1190.34
ng/l
0.51
86
676
18
84
2.21
2.40
1.1
1.1
—
—
—
0
0
161
1346
1.41
2.32
3.6
3.0
111.45
116.80
ug/l
0.12
146
1256
49
323
1.61
2.30
2.0
1.9
—
—
—
0
0
172
1457
1.41
2.28
4.5
3.7
0.00
0.00
estimate
-0.00
34
317
230
2065
1.44
2.09
5.0
4.3
14.24
11.44
mm/h
1.64
214
1915
113
901
1.40
2.09
5.0
4.2
5.38
8.10
mg/mmol
0.72
69
553
27
155
1.81
2.08
1.0
1.0
—
—
—
0
0
173
1485
1.37
2.02
4.6
3.8
0.00
0.01
estimate
0.50
31
290
26
149
1.81
2.02
1.6
1.3
—
—
—
0
0
27
158
1.78
1.96
12.9
8.4
15.33
15.77
%
0.24
27
152
41
271
1.59
1.92
5.7
3.3
5.99
5.84
kpa
0.43
41
265
130
1075
1.36
1.89
3.8
3.8
24.47
91.76
ng/l
0.68
94
752
170
1472
1.34
1.80
4.7
3.8
0.00
0.00
estimate
-0.00
33
315
86
670
1.39
1.79
3.0
2.3
—
—
—
0
0
14
67
2.14
1.79
1.8
1.3
129.25
297.60
ug/g
—
8
34
14
69
2.08
1.67
1.1
1.3
—
54.48
—
0
9
7
25
2.84
1.66
1.1
1.1
—
—
—
0
0
57
419
1.44
1.64
2.2
2.2
20.06
22.79
%
0.69
51
391
274
2581
1.53
1.61
21.3
15.1
84.70
83.00
ml/min/173m2
0.66
252
2385
65
491
1.41
1.61
1.5
1.3
21.05
8.00
u/ml
0.54
24
199
12
58
2.11
1.51
4.5
6.6
—
147.57
—
0
7
24
149
1.66
1.46
1.7
2.2
—
—
—
0
0
34
231
1.53
1.44
5.4
2.8
4.51
4.30
kpa
0.29
34
224
7
29
2.45
1.40
1.1
1.1
—
79.00
—
0
6
31
210
1.53
1.34
2.7
2.7
67.25
64.06
ml/min/173m2
0.19
12
99
0
41
0.00
1.32
0.0
1.1
—
1.08
—
0
9
23
146
1.62
1.30
1.6
1.4
—
—
—
0
0
8
34
2.39
1.30
1.3
1.1
—
—
—
0
0
10
48
2.12
1.29
1.6
1.2
—
—
—
0
0
10
48
2.12
1.29
1.6
1.2
—
—
—
0
0
8
35
2.32
1.28
1.3
1.1
—
—
—
0
0
28
188
1.54
1.26
2.1
2.2
—
—
—
0
0
23
148
1.60
1.24
3.3
2.6
0.53
0.63
%
1.39
23
148
40
292
1.42
1.21
3.3
2.5
67.10
31.90
u/l
0.76
31
241
240
2241
1.31
1.21
29.1
19.7
331.57
332.36
g/l
0.67
240
2235
31
216
1.48
1.19
1.6
1.4
—
—
—
0
0
8
41
1.98
1.09
1.6
1.5
—
—
—
0
0
11
59
1.90
1.08
1.5
1.4
—
—
—
0
0
7
33
2.15
1.06
2.6
3.6
2.77
2.87
nmol/l
—
7
33
21
138
1.56
1.06
1.5
2.0
3.18
5.59
iu/ml
—
5
39
14
83
1.72
1.03
1.3
1.2
—
—
—
0
0
25
173
1.48
1.01
5.1
3.0
134.36
130.82
g/l
0.32
25
168
64
521
1.29
0.99
3.7
3.8
356.17
243.52
ng/l
0.14
52
386
96
822
1.24
0.98
4.4
3.8
0.00
0.00
estimate
0.50
34
290
7
36
1.97
0.97
1.1
1.1
—
—
—
0
0
38
287
1.37
0.97
4.0
3.3
—
—
—
0
0
18
117
1.57
0.96
1.2
2.5
1.88
1.40
g/l
0.84
12
105
290
2810
1.50
0.95
15.1
12.2
24.42
26.60
u/l
2.19
282
2741
7
37
1.91
0.94
2.7
3.8
—
—
—
0
0
39
298
1.35
0.93
10.4
7.5
—
—
—
0
0
136
1213
1.22
0.93
2.3
2.0
100.70
97.63
pmol/l
0.27
68
611
74
621
1.25
0.90
4.5
4.4
24.28
21.74
%
0.68
36
286
25
179
1.43
0.87
15.0
9.8
25.52
24.30
mmol/l
1.02
25
174
11
65
1.72
0.83
2.1
2.2
127.60
126.71
g/l
—
5
48
74
627
1.24
0.82
4.6
3.8
1.02
1.02
kg/l
0.77
57
422
8
47
1.72
0.81
1.4
1.7
—
—
—
0
0
14
90
1.58
0.79
1.4
1.7
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
16.54
—
0
12
267
2570
1.28
0.77
5.8
5.0
6.11
5.95
mmol/l
0.90
244
2373
184
1709
1.19
0.77
3.4
3.2
—
—
—
0
0
10
59
1.72
0.76
1.4
1.6
—
—
—
0
0
5
24
2.10
0.75
1.6
1.4
—
—
—
0
0
22
159
1.41
0.74
1.6
1.7
—
—
—
0
0
15
100
1.53
0.74
2.2
2.0
663.00
277.76
ug/l
0.28
15
95
5
25
2.02
0.73
1.2
1.2
201.40
383.73
u/l
—
5
25
199
1870
1.18
0.69
3.6
3.3
40.07
48.71
u/l
1.22
188
1768
51
425
1.24
0.67
1.5
1.5
—
—
—
0
0
10
62
1.63
0.66
1.6
1.5
—
—
—
0
0
14
95
1.50
0.65
1.1
1.1
0.81
0.89
g/l
0.76
14
95
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
11
71
1.57
0.63
1.6
1.3
—
—
—
0
0
29
228
1.30
0.61
3.4
2.6
12.44
14.06
nmol/l
0.52
24
212
14
97
1.46
0.60
2.7
2.5
1.30
1.45
mg/l
0.54
14
88
14
97
1.46
0.60
1.4
1.8
—
—
—
0
0
11
72
1.55
0.60
1.5
1.6
—
—
—
0
0
10
64
1.58
0.59
1.5
3.0
5.67
9.15
pmol/l
—
10
64
15
107
1.42
0.56
2.0
1.8
0.50
5.15
ug/l
1.06
15
96
12
82
1.48
0.55
1.2
1.3
—
—
—
0
0
6
39
1.55
0.53
1.2
1.5
—
—
—
0
0
6
40
1.51
0.52
1.2
1.5
—
—
—
0
0
55
476
1.19
0.51
2.9
3.2
0.68
0.75
ug/l
0.49
27
300
259
2511
1.19
0.51
7.8
6.3
40.45
39.11
mmol/mol
1.38
241
2362
17
127
1.36
0.50
5.9
4.3
1.57
1.53
%
0.08
17
118
13
93
1.42
0.49
1.1
1.1
1.47
1.58
g/l
0.73
13
93
7
47
1.50
0.48
1.1
1.2
—
—
—
0
0
7
47
1.50
0.48
1.0
1.5
0.45
0.44
nmol/l
—
7
37
14
104
1.36
0.44
3.4
2.1
3723.63
5376.31
u/l
—
7
41
5
31
1.62
0.43
1.0
2.9
—
21.95
—
0
13
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
5
35
1.44
0.39
1.0
1.4
—
—
—
0
0
5
35
1.44
0.39
3.4
2.8
105.40
105.71
mmol/l
—
5
35
5
35
1.44
0.39
3.4
2.8
1.21
1.19
mmol/l
—
5
35
119
1111
1.12
0.39
4.6
3.6
0.00
0.02
estimate
0.80
30
264
5
36
1.40
0.38
1.0
1.4
—
—
—
0
0
5
36
1.40
0.38
1.0
1.4
—
—
—
0
0
5
36
1.40
0.38
1.4
1.5
—
—
—
0
0
5
36
1.40
0.38
1.0
1.4
—
—
—
0
0
5
36
1.40
0.38
1.0
1.4
—
—
—
0
0
5
36
1.40
0.38
1.0
1.4
—
—
—
0
0
9
71
1.28
0.36
2.1
1.7
—
—
—
0
0
6
43
1.40
0.35
2.8
1.9
—
—
—
0
0
6
43
1.40
0.35
1.8
1.4
—
—
—
0
0
269
2637
1.15
0.33
5.7
5.1
4.63
4.63
mmol/l
0.03
252
2472
272
2670
1.15
0.32
6.6
5.8
2.71
2.71
mmol/l
0.01
250
2489
7
54
1.30
0.30
1.7
1.7
—
—
—
0
0
10
75
1.34
0.30
1.6
1.5
—
—
—
0
0
11
84
1.32
0.30
1.6
1.7
—
—
—
0
0
7
56
1.26
0.29
1.4
1.2
14.51
16.33
u/l
—
7
47
40
356
1.14
0.29
3.5
2.2
—
—
—
0
0
267
2622
1.13
0.28
5.6
5.0
1.45
1.48
mmol/l
0.58
247
2444
6
84
0.71
0.24
1.2
1.3
—
—
—
0
0
36
323
1.13
0.24
3.2
2.0
—
—
—
0
0
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
7.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
384.60
—
0
5
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
9.23
—
0
13
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
6
48
1.25
0.20
1.0
1.4
—
256.67
—
0
6
6
48
1.25
0.20
1.0
1.4
—
—
—
0
0
10
81
1.24
0.19
1.5
1.5
—
—
—
0
0
10
81
1.24
0.19
1.5
1.3
—
—
—
0
0
7
58
1.21
0.18
1.7
1.7
—
—
—
0
0
7
61
1.15
0.17
1.3
1.2
—
—
—
0
0
7
62
1.13
0.17
1.4
1.6
—
—
—
0
0
12
101
1.20
0.17
1.3
1.3
—
—
—
0
0
17
149
1.15
0.16
1.9
2.8
60.18
45.94
u/ml
0.18
17
144
9
83
1.09
0.15
1.7
1.6
—
—
—
0
0
31
286
1.09
0.14
1.9
2.1
3.39
3.45
ratio
0.11
23
235
79
823
0.95
0.13
4.3
3.2
0.00
0.00
estimate
-0.00
30
253
11
94
1.18
0.13
3.0
1.9
31.73
39.42
nmol/l
0.56
11
88
120
1171
1.04
0.10
2.3
2.0
1.52
1.37
mmol/l
0.80
96
988
34
361
0.93
0.10
1.8
1.9
1.46
1.50
%
0.10
27
314
253
2508
1.05
0.09
4.7
4.2
1.32
1.27
mmol/l
0.53
234
2323
10
88
1.14
0.08
1.1
1.3
—
—
—
0
0
7
64
1.10
0.08
1.0
1.2
—
—
—
0
0
81
789
1.04
0.07
5.1
5.1
2.01
2.47
ug/l
0.38
76
708
65
631
1.04
0.07
1.8
1.7
2.07
1.32
mg/l
0.87
50
499
12
109
1.10
0.06
1.3
1.4
—
—
—
0
0
21
220
0.95
0.03
1.9
1.9
3.51
3.56
mmol/l
0.06
13
164
11
103
1.07
0.02
2.0
1.8
—
—
—
0
0
19
192
0.99
0.00
1.1
1.3
142.32
174.27
u/ml
—
6
72
34
343
0.99
0.00
5.5
4.9
27.95
32.25
%
1.96
19
226
0
9
0.00
-0.00
0.0
1.0
—
62.27
—
0
9
9
89
1.01
-0.00
1.9
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
5
55
0.91
-0.00
1.4
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_PHARYNX_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PHARYNX_NOS | 1.166 [0.87, 1.55] | 0.296 |
| Birth year | 0.993 [0.98, 1.0] | 0.132 |
During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 643 females with CD2_BENIGN_PHARYNX_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PHARYNX_NOS | 2.047 [1.56, 2.68] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.064 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 559 males with CD2_BENIGN_PHARYNX_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_PHARYNX_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.078% | 0.443% |
| 5 | 0.59% | 2.697% |
| 10 | 1.432% | 6.434% |
| 15 | 2.974% | 12.222% |
| 20 | 5.547% | 19.808% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PHARYNX_NOS – Benign neoplasm: Pharynx, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data